Less than a year after the Supreme Court overturned Roe v. Wade, some states are rethinking their abortion bans. This week, reporter Alice Miranda Ollstein introduces us to a Republican lawmaker pushing to add exceptions to the ban he helped pass, and we consider how well exceptions work - or don't - in practice.  Guests: Alice Miranda Ollstein, Health Care Reporter, Politico State Sen. Richard Briggs, MD, Tennessee General Assembly Yarnell Beatty, JD, Senior Vice President and General Counsel, Tennessee Medical Association Will Brewer, JD, Director of Government Relations, Tennessee Ri ..read more

Meet the man behind our revamped research newsletter bringing you the latest health policy studies, original analysis, interviews with leading researchers and more every Tuesday. Subscribe at tradeoffs.org/research Guest: Soleil Shah, Research Reporter, Tradeoffs Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news. Support this type of journalism today, with a gift. Follow us on Twitter.  Hosted on Acast. See acast.com/privacy for more information ..read more

Later this year the Supreme Court is set to decide whether to close a legal pathway that Medicaid recipients have used for more than 50 years. This week, we talk with Farah Yousry about the potential consequences of this decision. Guests: Farah Yousry, Health Equity Reporter, Side Effects Public Media Susie Talevski, patient Chris Schandevel, Senior Counsel, Alliance Defending Freedom Jane Perkins, Litigation Director, National Health Law Program Learn more and read a full transcript on our website. Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health poli ..read more

Medicare’s historic plan to slow prescription drug spending is taking shape. Last Thursday federal health officials began detailing how one of two major drug price reforms contained in the Inflation Reduction Act will work and who it will affect.  This week, we talk with Medicare director Meena Seshamani about the “opportunity of a lifetime” to put these unprecedented policies into action. Guest: Meena Seshamani, MD, PhD, Director of the Center for Medicare and Deputy Administrator, Centers for Medicare and Medicaid Services Learn more and read a full transcript on our website. Want m ..read more

One year of health insurance premiums for a family of four now costs as much as a car. Nine states are trying to lower those costs in an aggressive way - by holding hospitals and insurance companies accountable for high spending. In this episode we look to see if any of those efforts have bent the cost curve. Guests:  Leemore Dafny, PhD, Harvard University economist Michael Bailit, MBA President and Founder Bailit Health David Seltz, Executive Director Massachusetts Health Policy Commission Amy Rosenthal, MPH, MPA Executive Director Health Care For All Learn more and read a full transcr ..read more

Popping into the feed with a bit of breaking news on a story we've been reporting on for months: For the first time ever, some people incarcerated in jail or prison will have access to Medicaid. We'll have a full episode on this dramatic policy change in February. Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff. Support this type of journalism today, with a gift. Follow us on Twitter @tradeoffspod. Hosted on Acast. See acast.com/privacy for more information ..read more

After 20 years, Humira – the best selling drug of all time – is finally facing direct competition. Typically, once generic drugs arrive on a market they dominate sales and deliver big savings. But Humira’s competitors, known as biosimilars, aren’t like most other generics. This week, what makes this prescription drug showdown so unusual – and so important. Guest: Marta Wosińska, PhD, Visiting Fellow, Brookings Institution Learn more and read a full transcript on our website. Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news. S ..read more

A congressional ban on removing anyone from Medicaid will expire early next year. What will happen to people who lose their coverage, and how are states preparing for this unprecedented undertaking? Guests:  Elizabeth Nash, Principle Policy Associate, State Issues Cindy Mann, Partner, Manatt Health  Rachel Cohrs, Washington Correspondent, STAT Learn more and read a full transcript on our website. Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news. Support this type of journalism today, with a gift. Follow us on Twitte ..read more

We've got a lot to share with you in 2023! We're looking into what might happen to the marketplace as Humira, the best selling prescription drug in history, goes generic; and profile a woman pioneering a new strategy to help people better manage their own health, a strategy that has insurance companies whispering. The FDA has approved another controversial Alzheimer’s drug, Medicare is gearing up to negotiate drug prices, millions of Americans could lose their Medicaid…and, of course, abortion. Tradeoffs is here to take you through the health care year ahead. We’ll explore the policies and p ..read more

The leader of a landmark abortion study shares what research and her own family experience suggest will happen to people who are denied abortions in a post-Roe world. Guests:  Diana Foster Green, director of research at Advancing New Standards in Reproductive Health Read a full transcript and dig deeper into the issues explored in today's episode on our website. Support this type of journalism today by making a donation. Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff. Follow us on Twitter. Hoste ..read more